Literature DB >> 25535140

Protective effects of melatonin on ischemia-reperfusion induced myocardial damage and hemodynamic recovery in rats.

L-F Liu1, Q Qin, Z-H Qian, M Shi, Q-C Deng, W-P Zhu, H Zhang, X-M Tao, Y Liu.   

Abstract

AIM: To investigate the mechanism of melatonin (MT) protection of adult rate myocardial ischemia-reperfusion injury and its influence on rat's hemodynamic recovery.
MATERIALS AND METHODS: 48 rats were randomly divided into MT group (n=36) and the control group (n=12), MT group was divided into three sub-groups according to different dosages: Group I (n=12) was administered with 2.5 mg/kg MT; Group II (n=12) was administered with 5 mg/kg MT; Group III (n=12) was administered with 10 mg/kg MT. The electrocardiogram of four groups was observed with the left coronary artery blocked for 10min at first and then reperfused for 15min. Hemodynamic evolving was observed and changes in energy metabolism of rat myocardium were monitored. TUNEL and immunohistochemistry were applied to detect the cell apoptosis index, protein expression of Bcl-2 and Bax.
RESULTS: LVDP (left ventricular developed pressure) and ± dp/dt in MT group presented better recovery at various time points than the control group. Among them, Group III had the optimal recovery degree (p < 0.05). After MT administration, ATP content in myocardial cells in MT group was significantly higher than the control group. Compared with the control group, the concentration of mitochondrial MDA and Ca2+ in myocardial cells in MT group showed a downward trend. But its GSH concentration was significantly higher than the control group (p < 0.05). The improvement degree of ATP, MDA, GSH and Ca2+ concentration in Group II over-performed Group I (p < 0.05). MT-intervened myocardial apoptosis index (AI) and Bax positive expression index declined while Bcl-2 positive expression index increased (p < 0.01).
CONCLUSIONS: MT effectively inhibited myocardial apoptosis during the myocardial ischemia-reperfusion of rats, protected the structural integrity of mitochondria in myocardial cells, promoted ATP synthesis, and avoided heart damage in many ways. This protection mechanism was related with anti-oxidative damage. Meanwhile, MT could promote the hemodynamic recovery after myocardial ischemia-reperfusion in rats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25535140

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  15 in total

1.  Agomelatine protects against myocardial ischemia reperfusion injury by inhibiting mitochondrial permeability transition pore opening.

Authors:  Pengyu Jia; Chunting Liu; Nan Wu; Dalin Jia; Yingxian Sun
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 2.  Melatonin as a protective agent in cardiac ischemia-reperfusion injury: Vision/Illusion?

Authors:  Puneet Kaur Randhawa; Manish Kumar Gupta
Journal:  Eur J Pharmacol       Date:  2020-08-26       Impact factor: 4.432

3.  Melatonin alleviates hypoxia-induced cardiac apoptosis through PI3K/Akt pathway.

Authors:  Gui-Ping Luo; Zhao Jian; Rui-Yan Ma; Zhe-Zhe Cao; Yun Zhu; Yu Zhu; Fu-Qin Tang; Ying-Bin Xiao
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

4.  Effect of Intracoronary and Intravenous Melatonin on Myocardial Salvage Index in Patients with ST-Elevation Myocardial Infarction: a Randomized Placebo Controlled Trial.

Authors:  Sarah Ekeloef; Natalie Halladin; Siv Fonnes; Svend Eggert Jensen; Tomas Zaremba; Jacob Rosenberg; Grete Jonsson; Jens Aarøe; Lærke Smidt Gasbjerg; Mette Marie Rosenkilde; Ismail Gögenur
Journal:  J Cardiovasc Transl Res       Date:  2017-10-12       Impact factor: 4.132

Review 5.  Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3.

Authors:  Russel J Reiter; Dun Xian Tan; Sergio Rosales-Corral; Annia Galano; Mei-Jie Jou; Dario Acuna-Castroviejo
Journal:  Int J Mol Sci       Date:  2018-08-18       Impact factor: 5.923

6.  Ischemic postconditioning reduced myocardial ischemia-reperfusion injury: The roles of melatonin and uncoupling protein 3.

Authors:  Gülnur Aslan; Hüseyin Fatih Gül; Ahmet Tektemur; Engin Sahna
Journal:  Anatol J Cardiol       Date:  2020-01       Impact factor: 1.596

Review 7.  Clinical Application of Melatonin in the Treatment of Cardiovascular Diseases: Current Evidence and New Insights into the Cardioprotective and Cardiotherapeutic Properties.

Authors:  Mohammad Hossein Pourhanifeh; Ehsan Dehdashtian; Azam Hosseinzadeh; Seyed Hashem Sezavar; Saeed Mehrzadi
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-14       Impact factor: 3.727

8.  Influence of melatonin on IL-1Ra gene and IL-1 expression in rats with liver ischemia reperfusion injury.

Authors:  Hong Zhou; Chunhui Jiang; Lei Gu; Y E Liu; Longci Sun; Qing Xu
Journal:  Biomed Rep       Date:  2016-04-04

Review 9.  Effects of melatonin on cardiovascular diseases: progress in the past year.

Authors:  Hang Sun; Aaron M Gusdon; Shen Qu
Journal:  Curr Opin Lipidol       Date:  2016-08       Impact factor: 4.776

10.  Trimetazidine protects against cardiac ischemia/reperfusion injury via effects on cardiac miRNA‑21 expression, Akt and the Bcl‑2/Bax pathway.

Authors:  Ning Ma; Jingyun Bai; Weihua Zhang; Hong Luo; Xin Zhang; Donghai Liu; Chenhui Qiao
Journal:  Mol Med Rep       Date:  2016-09-26       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.